Spots Global Cancer Trial Database for localized prostate cancer
Every month we try and update this database with for localized prostate cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Active Surveillance Exercise Clinical Trial | NCT02435472 | Localized Prost... Active Surveill... | Exercise Cardiopulmonary... | 18 Years - | University of California, San Francisco | |
Posterior Urethrovesical Anastomotic Reconstruction in Comparison to Conventional Urethrovesical Anastomosis | NCT05605171 | Prostate Cancer | Posterior recon... Conventional ve... | 18 Years - | St. Joseph's Healthcare Hamilton | |
Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON) | NCT04569461 | Prostate Cancer | pembrolizumab Stereotactic bo... Short-term andr... Radical Prostat... | 18 Years - | Duke University | |
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs | NCT06051942 | Benign Prostati... Localized Prost... | Robotic Waterje... | - 80 Years | PROCEPT BioRobotics | |
Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer | NCT03886493 | Prostate Cancer | Dupilumab | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure | NCT00305929 | Prostate Cancer | Treatment with ... Treatment with ... Treatment with ... | - | STEBA France | |
Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful Waiting | NCT00717613 | Localized Prost... | 18 Years - | Baylor College of Medicine | ||
Active Surveillance Exercise Clinical Trial | NCT02435472 | Localized Prost... Active Surveill... | Exercise Cardiopulmonary... | 18 Years - | University of California, San Francisco | |
Personal Patient Profile Prostate (P4) Randomized, Multisite Trial | NCT00692653 | Prostate Cancer | P4 | 21 Years - | Dana-Farber Cancer Institute | |
Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial | NCT02024685 | Adenocarcinoma ... Adenocarcinoma ... Adenocarcinoma ... Adenocarcinoma ... | Personalized Tr... Standard patien... | - | Case Comprehensive Cancer Center | |
Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer | NCT04225299 | Localized Prost... | TOOKAD® | 18 Years - | Steba Biotech S.A. | |
MRI- Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer | NCT03996005 | MRI Guided Tran... Localized Prost... Ablation Therap... | Magnetic Resona... | 80 Years - | University Hospital, Strasbourg, France | |
Targeted Cryoablation of Prostate Cancer Lesions: An Investigator-initiated Trial | NCT05500846 | Prostate Cancer | The Visual Ice ... | 20 Years - 85 Years | Kyoto Prefectural University of Medicine | |
Focal MR-Guided Focused Ultrasound Treatment of Localized Low-Intermediate Risk Prostate Cancer: Feasibility Study | NCT01226576 | Localized Low-I... | MRgFUS Treatmen... | 50 Years - 75 Years | InSightec | |
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy | NCT03821246 | Prostate Adenoc... Prostate Cancer Localized Prost... | Atezolizumab Tocilizumab Etrumadenant | 18 Years - | University of California, San Francisco | |
Study In Urology Practices Looking At Impact Of OncotypeDX GPS Test On Men Choosing And Remaining On Active Surveillance | NCT03502213 | Prostate Cancer | 50 Years - | Genomic Health®, Inc. | ||
Fusion Guided Focal Laser Ablation of Prostate Cancer | NCT02759744 | Prostate Cancer Prostate Neopla... | ultrasound imag... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
Genetic Analysis of Prostate Cancer to Identify Predictive Markers of Disease Relapse or Metastatic Evolution | NCT03421015 | Prostatic Neopl... | 18 Years - | University Hospital, Lille | ||
Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer | NCT00129025 | Prostate Cancer | Hypofractionate... | - | AHS Cancer Control Alberta | |
Active Surveillance Exercise Clinical Trial | NCT02435472 | Localized Prost... Active Surveill... | Exercise Cardiopulmonary... | 18 Years - | University of California, San Francisco | |
Posterior Urethrovesical Anastomotic Reconstruction in Comparison to Conventional Urethrovesical Anastomosis | NCT05605171 | Prostate Cancer | Posterior recon... Conventional ve... | 18 Years - | St. Joseph's Healthcare Hamilton | |
Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer | NCT00129025 | Prostate Cancer | Hypofractionate... | - | AHS Cancer Control Alberta | |
Cost-utility of Focal HIFU vs Prostatectomy | NCT05710861 | Prostate Cancer | F-HIFU Radical Prostat... | 50 Years - 75 Years | University Hospital, Bordeaux | |
PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System | NCT06054867 | Localized Prost... | Robotic Waterje... | 40 Years - | PROCEPT BioRobotics | |
Interactive Decision Aid for Men Diagnosed With Prostate Cancer | NCT04260737 | Prostate Cancer | Decision Aid fo... | 18 Years - | Reykjavik University | |
Evaluation of Focal Treatments of Localized Prostate Cancers With High Intensity Focused Ultrasound Using the Focal One® Device | NCT02662673 | Localized Prost... | Focal High Inte... | 50 Years - 80 Years | Hospices Civils de Lyon | |
Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful Waiting | NCT00717613 | Localized Prost... | 18 Years - | Baylor College of Medicine | ||
PSMA-Guided Ablation of the Prostate | NCT06003556 | Prostate Cancer Localized Prost... | PSMA-1007 Posit... | 50 Years - | University of Alberta | |
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy | NCT03821246 | Prostate Adenoc... Prostate Cancer Localized Prost... | Atezolizumab Tocilizumab Etrumadenant | 18 Years - | University of California, San Francisco | |
Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure | NCT00305929 | Prostate Cancer | Treatment with ... Treatment with ... Treatment with ... | - | STEBA France | |
Health Gatherings - For Your Health After Cancer | NCT03344757 | Prostate Neopla... Genital Neoplas... Urogenital Neop... Neoplasm, Prost... Genital Disease... Prostatic Disea... | Cultural CBSM Standard CBSM | 18 Years - | University of Miami | |
Personal Patient Profile Prostate (P4) Randomized, Multisite Trial | NCT00692653 | Prostate Cancer | P4 | 21 Years - | Dana-Farber Cancer Institute | |
A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy | NCT02159690 | Prostate Cancer Localized Prost... | Enzalutamide Abiraterone ace... Prednisone Dutasteride Degarelix | 18 Years - | Johns Hopkins University | |
MRI- Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer | NCT03996005 | MRI Guided Tran... Localized Prost... Ablation Therap... | Magnetic Resona... | 80 Years - | University Hospital, Strasbourg, France | |
Clinical Study of HIFU for Localized Prostate Cancer | NCT06362577 | Localized Prost... | EQ-5D-5L IPSS I... | 40 Years - | RenJi Hospital | |
Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate Cancer | NCT03814252 | Localized Prost... | MRI-TULSA | 18 Years - 95 Years | Turku University Hospital | |
A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate Cancer | NCT00777452 | Prostate Cancer | 43 Years - 82 Years | Samsung Medical Center | ||
Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant. | NCT01902680 | Localized Prost... | Focal brachythe... | 18 Years - | Institut Claudius Regaud | |
Targeted Cryoablation of Prostate Cancer Lesions: An Investigator-initiated Trial | NCT05500846 | Prostate Cancer | The Visual Ice ... | 20 Years - 85 Years | Kyoto Prefectural University of Medicine | |
Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant. | NCT01902680 | Localized Prost... | Focal brachythe... | 18 Years - | Institut Claudius Regaud | |
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy | NCT05327465 | Androgen Depriv... Prostate Cancer Prostate Cancer... | Aerobic and res... Usual Care | 18 Years - | Dana-Farber Cancer Institute | |
Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer | NCT01620515 | Prostate Cancer | NX-1207 2.5 mg NX-1207 15 mg | 45 Years - 85 Years | Nymox Corporation | |
The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance | NCT06117059 | Localized Prost... Low Risk Prosta... Intermediate Ri... | 3 fractions of ... | - | NHS Lothian | |
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy | NCT05155046 | Localized Prost... | 18F-DCFPyL | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure | NCT00305929 | Prostate Cancer | Treatment with ... Treatment with ... Treatment with ... | - | STEBA France | |
Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue | NCT00651417 | Localized Breas... Localized Prost... Patients Receiv... | Organic Germani... Placebo | 18 Years - | Arizona Oncology Services | |
Cost-utility of Focal HIFU vs Prostatectomy | NCT05710861 | Prostate Cancer | F-HIFU Radical Prostat... | 50 Years - 75 Years | University Hospital, Bordeaux | |
Hypo-Fractionated Radiation Therapy for Localized Prostate Cancer | NCT01677845 | Prostate Cancer | Radiation | 18 Years - | NYU Langone Health | |
Dose Escalation For INtraprostatic LEsions | NCT05851547 | Prostatic Neopl... | Prostate SBRT w... Triptorelin Inj... | 18 Years - | Ottawa Hospital Research Institute | |
Fusion Guided Focal Laser Ablation of Prostate Cancer | NCT02759744 | Prostate Cancer Prostate Neopla... | ultrasound imag... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
12 Fractions Carbon Ion Radiotherapy for Localized Prostate Cancer | NCT04724577 | Radiotherapy Prostate Cancer | carbon ion radi... | 45 Years - 85 Years | Shanghai Proton and Heavy Ion Center | |
Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer | NCT00223665 | Prostate Cancer | Flutamide Leuprolide Acet... | 21 Years - | University of Washington | |
The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance | NCT06117059 | Localized Prost... Low Risk Prosta... Intermediate Ri... | 3 fractions of ... | - | NHS Lothian |